<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95917">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02102256</url>
  </required_header>
  <id_info>
    <org_study_id>KSOM-ABI 001</org_study_id>
    <nct_id>NCT02102256</nct_id>
  </id_info>
  <brief_title>A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients</brief_title>
  <official_title>A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laurie Eisenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Keck School of Medicine of USC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huntington Medical Research Institutes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current treatment options for bilateral profoundly deaf children, diagnosed with inner ear
      anatomical abnormalities, are limited and, in the case of absent cochleas, non-existent. An
      auditory brainstem implant (ABI) places an electrode close to the auditory nucleus in the
      brainstem. Children aged 2 - 5 who are not candidates for a cochlear implant, or who did not
      demonstrate benefit from a cochlear implant, will be implanted with an ABI and followed for
      1 year for safety and a total of 3 years for preliminary efficacy. This is a feasibility
      study to determine the safety of the ABI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Primary endpoint</measure>
    <time_frame>12-months post-device activation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Serious adverse event (count) per subject.  Count of expected serious adverse events per subject.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary endpoint: Preliminary efficacy</measure>
    <time_frame>3 years post-device activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Access to sound at a level (dB) and with the frequency range (500-4000Hz), known to be associated with speech.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unexpected Serious Adverse Events</measure>
    <time_frame>12-months post-activation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Unexpected adverse events (count).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <condition>Profound Bilateral Deafness Due to</condition>
  <condition>Bilateral Cochlear Aplasia</condition>
  <condition>Bilateral Cochlear Nerve Deficiency</condition>
  <condition>Bilateral Cochlear Ossification Secondary to Meningitis</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device Implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Auditory Brainstem Implant</intervention_name>
    <arm_group_label>Experimental</arm_group_label>
    <other_name>Cochlear Corporation Nucleus 24</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral profound deafness due to cochlear aplasia, cochlear nerve deficiency, or
             ossification secondary to meningitis

          -  If previously received a cochlear implant, must demonstrate lack of benefit from that
             device

        Exclusion Criteria:

          -  Medical contraindication to craniotomy/intracranial surgery

          -  Severe cognitive or developmental delays
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie S. Eisenberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keck School of Medicine of USC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Wilkinson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huntington Medical Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Martinez, MS</last_name>
    <phone>213-764-2807</phone>
    <email>amy.martinez@med.usc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurie Eisenberg, PhD</last_name>
    <phone>213-764-2826</phone>
    <email>laurie.eisenberg@med.usc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keck School of Medicine of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Martinez, MS</last_name>
      <phone>213-764-2807</phone>
      <email>amy.martinez@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Laurie Eisenberg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>April 11, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Laurie Eisenberg</investigator_full_name>
    <investigator_title>Professor of Research Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>deafness</keyword>
  <keyword>congenital</keyword>
  <keyword>pediatric</keyword>
  <keyword>device</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Meningitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
